Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,774.75
(
2.39%
)
US TECH 100
24,216.00
(
2.86%
)
Dow Jones
47,820.07
(
2.65%
)
Brent Oil
93.72
(
-7.40%
)
Bitcoin
71,308.41
(
-0.94%
)
News Focus
News Focus
Post# of 257372
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122856
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: EZ2 post# 3756

Monday, 09/27/2004 7:57:39 PM

Monday, September 27, 2004 7:57:39 PM

Post# of 257372
Today’s Boston Globe noted that the Boston regional office of the SEC is targeting unspecified Boston-area biotech companies for possible securities violations.

Given the propensity for certain biotech companies to engage in unscrupulous behavior, I doubt this office will encounter a shortage of workload.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today